Stay updated on Pembrolizumab in Elderly Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Elderly Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Elderly Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:27:01.000Z thumbnail image
  4. Check
    35 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T10:14:27.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T09:27:32.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-19T23:50:14.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    0.2%
    Check dated 2025-01-12T18:51:49.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T22:52:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Elderly Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Elderly Lung Cancer Clinical Trial page.